Regression discontinuity analysis for pharmacovigilance: statin example reflected trial findings showing little evidence of harm. (2022)

First Author: Scott L

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jclinepi.2021.10.003

PubMed Identifier: 34648942

Publication URI: http://europepmc.org/abstract/MED/34648942

Type: Journal Article/Review

Volume: 141

Parent Publication: Journal of clinical epidemiology

ISSN: 0895-4356